Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colleen Burgess

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Pharmacoeconomics - Open|June 29, 2026
Estimating the Long-Term Clinical and Economic Impact of Universal Varicella Vaccination in Portugal Using a Dynamic Transmission ModelColleen Burgess, Stephanie A Kujawski, Miguel Amorim, et al.
Journal of Health Economics and Outcomes Research|October 5, 2022
The Long-Term Clinical and Economic Impact of Universal Varicella Vaccination in SloveniaColleen Burgess, Stephanie Kujawski, Ajda Lapornik, et al.
Vaccine|March 20, 2016
Impact of oral cholera vaccines in cholera-endemic countries: A mathematical modeling studyJong-Hoon Kim, Vittal Mogasale, Colleen Burgess, et al.
Plos One|July 8, 2021
Clinical and economic impact of universal varicella vaccination in Norway: A modeling studyManjiri Pawaskar, Colleen Burgess, Mathew Pillsbury, et al.
PLOS Global Public Health|April 5, 2023
Universal varicella vaccination in Denmark: Modeling public health impact, age-shift, and cost-effectivenessColleen Burgess, Salome Samant, Thomas leFevre, et al.
PLOS Global Public Health|September 14, 2023
Correction: Universal varicella vaccination in Denmark: Modeling public health impact, age-shift, and cost-effectivenessColleen Burgess, Salome Samant, Thomas leFevre, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2021
Modeling Cost-Effectiveness of Universal Varicella Vaccination With Different Varicella Vaccines in the United KingdomManjiri Pawaskar, Colleen Burgess, Matthew Pillsbury, et al.
BMJ Global Health|July 10, 2023
Cost-effectiveness of measles and rubella elimination in low-income and middle-income countriesAnn Levin, Colleen Burgess, Stephanie Shendale, et al.
Human Vaccines & Immunotherapeutics|April 2, 2025
Modeling the effects of improving varicella vaccination coverage on clinical and economic outcomes in PeruJohn C Lang, Colleen Burgess, Salome Samant, et al.
Reproductive Biomedicine Online|August 10, 2006
Cryopreservation of unfertilized human oocytesJames J Stachecki, Jacques Cohen, John Garrisi, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Pharmacoeconomics - Open|June 29, 2026
Estimating the Long-Term Clinical and Economic Impact of Universal Varicella Vaccination in Portugal Using a Dynamic Transmission ModelColleen Burgess, Stephanie A Kujawski, Miguel Amorim, et al.
Journal of Health Economics and Outcomes Research|October 5, 2022
The Long-Term Clinical and Economic Impact of Universal Varicella Vaccination in SloveniaColleen Burgess, Stephanie Kujawski, Ajda Lapornik, et al.
Vaccine|March 20, 2016
Impact of oral cholera vaccines in cholera-endemic countries: A mathematical modeling studyJong-Hoon Kim, Vittal Mogasale, Colleen Burgess, et al.
Plos One|July 8, 2021
Clinical and economic impact of universal varicella vaccination in Norway: A modeling studyManjiri Pawaskar, Colleen Burgess, Mathew Pillsbury, et al.
PLOS Global Public Health|April 5, 2023
Universal varicella vaccination in Denmark: Modeling public health impact, age-shift, and cost-effectivenessColleen Burgess, Salome Samant, Thomas leFevre, et al.
PLOS Global Public Health|September 14, 2023
Correction: Universal varicella vaccination in Denmark: Modeling public health impact, age-shift, and cost-effectivenessColleen Burgess, Salome Samant, Thomas leFevre, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2021
Modeling Cost-Effectiveness of Universal Varicella Vaccination With Different Varicella Vaccines in the United KingdomManjiri Pawaskar, Colleen Burgess, Matthew Pillsbury, et al.
BMJ Global Health|July 10, 2023
Cost-effectiveness of measles and rubella elimination in low-income and middle-income countriesAnn Levin, Colleen Burgess, Stephanie Shendale, et al.
Human Vaccines & Immunotherapeutics|April 2, 2025
Modeling the effects of improving varicella vaccination coverage on clinical and economic outcomes in PeruJohn C Lang, Colleen Burgess, Salome Samant, et al.
Reproductive Biomedicine Online|August 10, 2006
Cryopreservation of unfertilized human oocytesJames J Stachecki, Jacques Cohen, John Garrisi, et al.
Pageof 3